Susan Gibson

commercial strategy, life cycle management, Pharma, medical device, marketing, new product planning, market research, competitive intelligence, managed care, supplements, GREAS, FDA, startups

Commercial Strategy, New Product Planning, Life Cycle Management, Payer Strategy

Founder & President, Vivolor Therapeutics

Susan Gibson has 30 years of commercial leadership experience in Pharma/Biotech and medical device industries encompassing marketing strategy, new product planning, market research, competitive intelligence, and managed care. She has successfully launched nine products and performed commercial assessments and forecasted commercial potential for over 30 products. Her areas of expertise include trends in healthcare, orphan drugs, lifecycle management, forecasting, and commercial assessments in the therapeutic areas of CNS, cardiovascular, sleep disorders and Alzheimer’s disease.

Ms. Gibson’s career path spans both entrepreneurial and corporate spectrum. She is currently the Founder and President of Vivolor™ Therapeutics Inc., creator of the revolutionary nutraceutical, Glory Day™ Brain Booster – an all-natural product designed to address the underlying cause of brain decline and memory loss in dementia. Prior to founding Vivolor, Ms. Gibson was the Head of Commercial Development and Market Intelligence at Jazz Pharmaceuticals®, as well as the Commercial Lead for SUNOSITM (solriamfetol). Ms. Gibson’s past career roles include leadership positions in managed care at Genentech, Vice President of Marketing at EndoGastric Solutions, and Founder and President of Eve Group Inc. a marketing strategy consulting firm.

Ms. Gibson received 2019 Top 100 Healthcare Leaders award from the International Forum for Advancements in Healthcare. She serves on the Board of Directors of Linnet Pharmaceuticals and two non-profit organizations. Ms. Gibson holds a Pharmacy degree from Purdue University and an MBA from Harvard Graduate School of Business.